Figure 7From: Estimating the budget impact of orphan drugs in Sweden and France 2013–2020Pharmaceutical market growth. French and Swedish data are each observed for 2000–2012 [17, 18]. Both countries are modeled forward from 2013 using a 2% per annum growth assumption.Back to article page